TABLE 1.
Telavancin depolarization activity against phenotypically diverse S. aureus isolates
| Strain | Relevant phenotype | % Depolarizationa |
|---|---|---|
| ATCC 33591 | Methicillin resistant | 77 ± 7 |
| ATCC 700699 | Vancomycin intermediate (Mu50) | 61 ± 3 |
| ATCC 700698 | Heterogeneous vancomycin intermediate (Mu3) | 78 ± 4 |
| MED 2034 | Daptomycin nonsusceptible | 77 ± 5 |
a
Percent depolarization is reported for treatment with 32 μg/ml telavancin, and the values represent the means ± standard deviations from at least three independent experiments.